Plantation, FL3 Active Studies

Pulmonary Hypertension Clinical Trials in Plantation, FL

Find 3 actively recruiting pulmonary hypertension clinical trials in Plantation, FL. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
752
Enrolling

Recruiting Pulmonary Hypertension Studies in Plantation

About Pulmonary Hypertension Clinical Trials in Plantation

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 3 pulmonary hypertension clinical trials recruiting participants in Plantation, FL. These studies are seeking a combined 752 participants. Research is being sponsored by Regeneron Pharmaceuticals, ImmunoVaccine Technologies, Inc. (IMV Inc.), National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Plantation — FAQ

Are there pulmonary hypertension clinical trials in Plantation?

Yes, there are 3 pulmonary hypertension clinical trials currently recruiting in Plantation, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Plantation?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Plantation research site will contact you about next steps.

Are clinical trials in Plantation free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Plantation studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 3 active trials in Plantation are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated October 12, 2026 from ClinicalTrials.gov